ArticleBiomedicines2022

Androstenedione and Follicle-Stimulating Hormone Concentration Predict the Progression of Frailty Syndrome at One Year Follow-Up in Patients with Localized Breast Cancer Treated with Aromatase Inhibitors.

Javier García-Sánchez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.